Suboptimal Intermittent Preventive Treatment in Pregnancy (IPTp) is Associated With an Increased Risk of Submicroscopic Plasmodium falciparum Infection in Pregnant Women: A Prospective Cohort Study in Benin
Open Access
- 9 September 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (11) , e3759-e3767
Abstract
Harmful maternal and neonatal health outcomes result from malaria in pregnancy, the prevention of which primarily relies on intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP). The World Health Organization recommends IPTp-SP in sub-Saharan Africa, but implementation is highly heterogeneous and often suboptimal in terms of the number of doses and their timing. In this study, we assessed the impact of this heterogeneity on malaria in pregnancy, mainly with respect to submicroscopic Plasmodium falciparum infections. We used data from 273 Beninese women followed throughout pregnancy. Screening for P. falciparum infections, using both microscopy-based and polymerase chain reaction (PCR)–based methods, was performed monthly, and information on IPTp-SP doses was collected. Gestational age was estimated by repeated ultrasound scans. Using a negative binomial model, we investigated the effect of IPTp-SP doses and timing after 17 weeks of gestation on the number of P. falciparum infections, focusing on submicroscopic infections detectable only by PCR. At least 2 IPTp-SP doses were taken by 77.3% of the women. The median gestational age at the first IPTp-SP dose was 22 weeks. A late first IPTp-SP dose (>21.2 weeks) was marginally associated with an increased number of P. falciparum infections (adjusted incidence rate ratio [aIRR] = 1.3; P = .098). The number of IPTp-SP doses was not associated with the number of submicroscopic infections (aIRR = 1.2, P = .543). A late first IPTp-SP dose failed to provide optimal protection against P. falciparum, especially submicroscopic infections. This highlights the need for a new antimalarial drug for IPTp that could be taken early in pregnancy.Keywords
Funding Information
- French Agence Nationale de la Recherche (ANR-13-JSV1–0004)
- Fondation Simone Beer under the auspices of the Fondation de France (00074147)
This publication has 29 references indexed in Scilit:
- Factors Affecting the Delivery, Access, and Use of Interventions to Prevent Malaria in Pregnancy in Sub-Saharan Africa: A Systematic Review and Meta-AnalysisPLOS Medicine, 2013
- Prevention of Malaria in Pregnancy with Intermittent Preventive Treatment and Insecticide Treated Nets in Mali: A Quantitative Health Systems Effectiveness AnalysisPLOS ONE, 2013
- Consequences of Gestational Malaria on Birth Weight: Finding the Best Timeframe for Intermittent Preventive Treatment AdministrationPLOS ONE, 2012
- Maternal malaria status and metabolic profiles in pregnancy and in cord blood: relationships with birth size in Nigerian infantsMalaria Journal, 2012
- Asymptomatic Carriage of Plasmodium in Urban Dakar: The Risk of Malaria Should Not Be UnderestimatedPLOS ONE, 2012
- Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccineMalaria Journal, 2011
- Field evaluation of the intermittent preventive treatment of malaria during pregnancy (IPTp) in Benin: evolution of the coverage rate since its implementationParasites & Vectors, 2011
- Malaria Prevention with IPTp during Pregnancy Reduces Neonatal MortalityPLOS ONE, 2010
- Submicroscopic Infection inPlasmodium falciparum–Endemic Populations: A Systematic Review and Meta‐AnalysisThe Journal of Infectious Diseases, 2009
- Real-Time Quantitative PCR for Determining the Burden ofPlasmodium falciparumParasites during Pregnancy and InfancyJournal of Clinical Microbiology, 2005